145 related articles for article (PubMed ID: 26308418)
1. Serum Antiphospholipid Antibodies in Transplanted Patients: Potential Follow-up Markers to Assess Pregnancy Risk?
Ortona E; Colasanti T; Derme M; Iannini I; Vomero M; Sorice M; D'Alessandro F; Costa AN; Malorni W; Orlando G; Framarino-dei-Malatesta M
Transplantation; 2015 Sep; 99(9):e152-4. PubMed ID: 26308418
[No Abstract] [Full Text] [Related]
2. Interpretation and recommended testing for antiphospholipid antibodies.
Galli M
Semin Thromb Hemost; 2012 Jun; 38(4):348-52. PubMed ID: 22399305
[TBL] [Abstract][Full Text] [Related]
3. Anti-oxidised-phospholipid antibodies do not correlate with specific anti-phospholipid syndrome classes, but with disease duration.
Musetti C; Quaglia M; Cena T; Rizzo A; Stratta P; Albano E
Thromb Haemost; 2014 Feb; 111(2):378-80. PubMed ID: 24154830
[No Abstract] [Full Text] [Related]
4. The significance of antiphospholipid antibodies in pregnant women with chronic hypertension.
Zeeman GG; Alexander JM; McIntire DD; Leveno KJ
Am J Perinatol; 2004 Jul; 21(5):275-9. PubMed ID: 15232760
[TBL] [Abstract][Full Text] [Related]
5. [Antiphospholipid syndrome in pregnancy--contemporary opinions concerning pathogenesis and diagnostic criteria].
Matusiak-Kita M; Murawski M; Gryboś M
Wiad Lek; 2009; 62(1):21-5. PubMed ID: 19817253
[TBL] [Abstract][Full Text] [Related]
6. Mothers' antiphospholipid antibodies during pregnancy and the relation to offspring outcome.
Mekinian A; Carbillon L; Nicaise-Roland P; Rousseau H; Lachassinne E; Motta M; Vicaut E; Boinot C; Avcin T; De Carolis S; Rovere-Querini P; Lambert M; Derenne S; Pourrat O; Chollet-Martin S; Biasini-Rebaioli R; Rovelli R; Lojacono A; Ambrozic A; Benbara A; Pierre F; Allegri F; Nuzzo M; Hatron PY; Tincani A; Aurousseau MH; Boffa MC; Fain O
Clin Exp Rheumatol; 2014; 32(3):446. PubMed ID: 24847815
[No Abstract] [Full Text] [Related]
7. Beta 2-glycoprotein I is a good indicator of certain adverse pregnancy conditions.
Ulcová-Gallová Z; Bouse V; Krizanovská K; Balvín M; Rokyta Z; Netrvalová L
Int J Fertil Womens Med; 2001; 46(6):304-8. PubMed ID: 11795690
[TBL] [Abstract][Full Text] [Related]
8. [Antiphospholipid syndrome diagnosis: an update].
Visseaux B; Masliah-Planchon J; Fischer AM; Darnige L
Ann Biol Clin (Paris); 2011; 69(4):411-8. PubMed ID: 21896405
[TBL] [Abstract][Full Text] [Related]
9. [Apheresis in antiphospholipid syndrome (APS)].
De Silvestro G; Tison T; Marson P
G Ital Nefrol; 2012; 29 Suppl 54():S78-83. PubMed ID: 22388836
[TBL] [Abstract][Full Text] [Related]
10. Diagnosis and management of non-criteria obstetric antiphospholipid syndrome.
Arachchillage DR; Machin SJ; Mackie IJ; Cohen H
Thromb Haemost; 2015 Jan; 113(1):13-9. PubMed ID: 25318976
[TBL] [Abstract][Full Text] [Related]
11. [The antiphospholipid syndrome].
Oku K; Atsumi T
Rinsho Ketsueki; 2013 Feb; 54(2):179-88. PubMed ID: 23470825
[No Abstract] [Full Text] [Related]
12. Treatment of 139 pregnancies in antiphospholipid-positive women not fulfilling criteria for antiphospholipid syndrome: a retrospective study.
Del Ross T; Ruffatti A; Visentin MS; Tonello M; Calligaro A; Favaro M; Hoxha A; Punzi L
J Rheumatol; 2013 Apr; 40(4):425-9. PubMed ID: 23418380
[TBL] [Abstract][Full Text] [Related]
13. Decreased interleukin-35 levels are associated with higher risk of pregnancy morbidity in patients with antiphospholipid syndrome.
Zhang SL; Liu N; Wei XQ; Lu Q; Mu R; Li ZG
Clin Exp Rheumatol; 2016; 34(3):562-3. PubMed ID: 27086778
[No Abstract] [Full Text] [Related]
14. Antibodies to phosphatidylserine/prothrombin complex in suspected antiphospholipid syndrome in the absence of antibodies to cardiolipin or Beta-2-glycoprotein I.
Sanfelippo MJ; Joshi A; Schwartz S; Meister JA; Goldberg JW
Lupus; 2013 Nov; 22(13):1349-52. PubMed ID: 23989738
[TBL] [Abstract][Full Text] [Related]
15. Clinical manifestations of antiphospholipid syndrome (APS) with and without antiphospholipid antibodies (the so-called 'seronegative APS').
Rodriguez-Garcia JL; Bertolaccini ML; Cuadrado MJ; Sanna G; Ateka-Barrutia O; Khamashta MA
Ann Rheum Dis; 2012 Feb; 71(2):242-4. PubMed ID: 21953349
[TBL] [Abstract][Full Text] [Related]
16. [Antiphosphatidylethanolamine antibody as a marker of antiphospholipid syndrome?].
Yelnik CM; Dubucquoi S; Houfflin-Debarge V; Lambert M
Presse Med; 2015 Mar; 44(3):284-91. PubMed ID: 25542711
[TBL] [Abstract][Full Text] [Related]
17. [Management of antiphospholipid syndrome].
Atsumi T
Rinsho Ketsueki; 2009 Oct; 50(10):1427-33. PubMed ID: 19915351
[No Abstract] [Full Text] [Related]
18. Quantification of circulating fetal DNA as a tool for potential monitoring of pregnant patients with antiphospholipid antibodies.
Korabecna M; Ulcova-Gallova Z; Horinek A; Pazourková E; Calda P
Autoimmunity; 2014 Nov; 47(7):473-7. PubMed ID: 24829103
[TBL] [Abstract][Full Text] [Related]
19. Obstetric implications of antiphospholipid antibodies: pregnancy loss and other complications.
Geis W; Branch DW
Clin Obstet Gynecol; 2001 Mar; 44(1):2-10. PubMed ID: 11219242
[No Abstract] [Full Text] [Related]
20. Antiphospholipid antibodies.
Houghton DE; Moll S
Vasc Med; 2017 Dec; 22(6):545-550. PubMed ID: 29103369
[No Abstract] [Full Text] [Related]
[Next] [New Search]
